Navigation Links
MMJ BioPharma Cultivation Announces Plans To Grow DEA Licensed Cannabis In Partnership With Native American Tribe
Date:6/13/2019

MMJ BioPharma Cultivation, a premier medical cannabis cultivation and research company today announced that it has signed a memorandum of understanding (MOU) with MMJ International Holdings to grow cannabis and supply active pharmaceutical ingredients (API) for its drug product MMJ-001 and MMJ-002.

MMJ BioPharma Cultivation will be supplying MMJIH with extracts from the marijuana plant to support its investigational new drug (IND) filings with the FDA for Multiple Sclerosis and Huntington’s disease. It will also plan to meet the growing demand from hospitals, researchers, and scientist for their FDA/DEA approved clinical trials.

MMJ BioPharma Cultivation has applied for a DEA Schedule-I Bulk Manufacturer license to cultivate cannabis plants for this purpose. MMJ BioPharma Cultivation will facilitate a process of scientific drug development and discovery governed by FDA protocol development processes and DEA regulatory manufacturing guidelines.

To further meet the statutory requirements of the “public benefit” MMJ BioPharma Cultivation has entered into an agreement with a US Native Indian Tribe to perform its development activities. MMJ BioPharma Cultivation is planning a phased development program on Native American Tribal Trust lands of approximately 1 million square feet with a state of the art extraction analytics lab to meet DEA approved researchers needs. MMJ BioPharma Cultivation will be employing tribal members in its development and cultivation program.

Dr. Elio Mariani, a senior executive of the company and big pharma veteran stated “we are looking forward to our collaboration with the tribe in unlocking the potential of cannabinoid medicines to address serious medical conditions. Our efforts will be guided by the FDA and DEA as we strive to produce the highest pharma grade plants and extracts for clinical research.”

Read the full story at https://www.prweb.com/releases/mmj_biopharma_cultivation_announces_plans_to_grow_dea_licensed_cannabis_in_partnership_with_native_american_tribe/prweb16347165.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine news :

1. Biopharmaceutical Success Depends on Delivery, Fueling $7.8 BN Market: Report
2. Catalent Wins Prestigious Clinical Supply Chain Excellence Award at BioPharma Asia Convention
3. Accelerated Biopharmaceutical Development through Strategic Analytical Partnerships to be Discussed by Catalent Expert at Upcoming WCBP Conference
4. VetStem Biopharma Begins Enrollment in Pivotal FDA Clinical Study of Osteoarthritis in Dogs
5. Beckman Coulter Webinar Helps You Skirt the Pitfalls When Automating Cell Viability Counting for Biopharma QC
6. U.S. Ranks 1st in How Its National Policies Impact Global Biopharma Innovation, ITIF Finds in New Analysis Marking World Health Day
7. Reliable Biopharmaceutical Announces New Investor and Chairman
8. Optimizing Early Stage Drug Development and Best Practices in Clinical Trial Supply Management to be Presented by Catalent Experts at Biopharma Asia in Singapore
9. FDAnews Announces — The Biopharmaceutical Facility of the Future: To 2025 and Beyond Webinar, Sept. 29, 2015
10. Dr. Kevin Sadati Discusses the Impact of Allergan Acquiring KYTHERA Biopharmaceuticals
11. Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/12/2019)... ... August 12, 2019 , ... Israeli ... finding significant therapeutic benefits in the use of floristry as treatment for fibromyalgia. ... included a total of 61 female fibromyalgia patients participating in a 12-week floral ...
(Date:8/9/2019)... ... August 09, 2019 , ... ... of its global expansion into Europe’s third largest pharmaceutical market with the recent ... Clinical’s entrance into Italy now completes the organization’s thorough coverage of Western Europe. ...
(Date:8/9/2019)... (PRWEB) , ... August 09, 2019 , ... ... Centers Lebanon, its second opioid treatment program (OTP) in Ohio. MedMark Lebanon will ... opioid addiction. The clinic, located at 1521 Walmart Drive, is now accepting patients. ...
(Date:8/9/2019)... ... 08, 2019 , ... Guruji Mahendra Trivedi is an innovative ... practical and spiritual levels. , Founder of the Trivedi Effect®, Guruji Mahendra ... their understanding, as well as, to illuminate the path of awareness and higher ...
(Date:8/8/2019)... ... August 08, 2019 , ... Makers ... Customer Sales and Service World Awards® for its dedication to customers satisfaction and ... from a broad spectrum of industry voices, encompasses the world’s best in Sales ...
Breaking Medicine News(10 mins):
(Date:8/14/2019)... ... August 13, 2019 , ... ... and age together through the power of play, is proud to announce its ... 2019 Caregiver Friendly® Awards. Today’s Caregiver, the first national magazine for all family ...
(Date:8/12/2019)... ... August 12, 2019 , ... Dr. Kenrick ... chief authority in the field of cosmetic plastic and reconstructive surgery, Dr. Spence ... Dr. Spence for his knowledge and expertise in treating keloid scars . ...
(Date:8/12/2019)... ... ... Innovators and startup companies with devices designed to improve neonatal or NICU care now ... “Make Your Medical Device Pitch for Kids!” competition funded by the National Capital ... in Boston, Mass. in conjunction with the 7th Annual Pediatric Device Innovation Symposium ...
Breaking Medicine Technology: